Efficacy Of Montelukast For Allergic Rhinitis Concomitant With Asthma: Post-Hoc Analysis Based On New ARIA Guidelines

Efficacy Of Montelukast For Allergic Rhinitis Concomitant With Asthma: Post-Hoc Analysis Based On New ARIA Guidelines

Differences between montelukast and placebo were estimated in each ARIA category for the primary endpoint (Daily Rhinitis Symptoms Score, DRSS) and secondary endpoints (including Daytime Nasal Symptoms Score, DNSS), each rated on a 0-3-point scale (none to severe).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S51-S51
Hauptverfasser: Swern, A, Philip, G, Dong, Q, Dass, S.B, Reiss, T.F
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Comorbidity
Nose
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Differences between montelukast and placebo were estimated in each ARIA category for the primary endpoint (Daily Rhinitis Symptoms Score, DRSS) and secondary endpoints (including Daytime Nasal Symptoms Score, DNSS), each rated on a 0-3-point scale (none to severe).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.205